Renalytix AI PLC-ADR
13F holders, Q4 2024 (December 31)3holders −21
0new positions
22sold out
$0.20avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Renalytix AI PLC-ADR in their 13F filings, down 21 from Q3 2024. 0 opened new positions and 22 sold out. The largest holders were XTX Topco Ltd ($7K), Baader Bank Aktiengesellschaft ($5K) and Ironwood Investment Counsel, LLC ($2K).
- Company
- Renalytix AI PLC-ADR
- CUSIP
- 75973T101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 22 | $875K |
All 13F filers, Q3 2024 → Q4 2024: 21,826 shares bought and 3,453,122 shares sold, net −3,431,296 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| XTX Topco Ltd | 0.00% | Add +62.3% | 32,779 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | Add +61.4% | 24,289 | $5K |
| Ironwood Investment Counsel, LLC | 0.00% | Reduce -16.7% | 10,000 | $2K |
"% of holder's portfolio" is RENALYTIX AI PLC-ADR's weight in each manager's 13F, not the share of Renalytix AI PLC-ADR the manager owns.